Published in J Virol on March 01, 2000
Replication of human immunodeficiency viruses engineered with heterologous Tat-transactivation response element interactions. J Virol (2003) 0.90
A single intermolecular contact mediates intramolecular stabilization of both RNA and protein. Proc Natl Acad Sci U S A (2005) 0.82
Comparative functional analysis of Jembrana disease virus Tat protein on lentivirus long terminal repeat promoters: evidence for flexibility at its N-terminus. Virol J (2009) 0.75
Trans-activator gene of human T-lymphotropic virus type III (HTLV-III). Science (1985) 12.75
The trans-activator gene of the human T cell lymphotropic virus type III is required for replication. Cell (1986) 10.76
A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA. Cell (1998) 10.14
Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients. Science (1995) 10.02
Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. Nature (1995) 4.95
Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients. Nature (1990) 4.47
Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation. J Virol (1993) 3.68
Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein. Science (1995) 3.46
Site-directed mutagenesis of two trans-regulatory genes (tat-III,trs) of HIV-1. Science (1988) 3.36
Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcoma. Nature (1994) 3.05
Enhanced processivity of RNA polymerase II triggered by Tat-induced phosphorylation of its carboxy-terminal domain. Nature (1996) 2.92
How does HIV cause AIDS? Science (1993) 2.92
Host range, replicative, and cytopathic properties of human immunodeficiency virus type 1 are determined by very few amino acid changes in tat and gp120. J Virol (1991) 2.87
Productive, persistent infection of human colorectal cell lines with human immunodeficiency virus. J Virol (1987) 2.84
HIV-1 auxiliary proteins: making connections in a dying cell. Cell (1998) 2.68
High frequency of defective nef alleles in a long-term survivor with nonprogressive human immunodeficiency virus type 1 infection. J Virol (1996) 2.61
Functional domains required for tat-induced transcriptional activation of the HIV-1 long terminal repeat. EMBO J (1988) 2.57
Missense mutations in an infectious human immunodeficiency viral genome: functional mapping of tat and identification of the rev splice acceptor. Proc Natl Acad Sci U S A (1988) 2.55
Functional comparison of transactivation by simian immunodeficiency virus from rhesus macaques and human immunodeficiency virus type 1. J Virol (1988) 2.00
Effects of the human immunodeficiency virus type 1 Tat protein on the expression of inflammatory cytokines. J Virol (1992) 1.97
New human and simian HIV-related retroviruses possess functional transactivator (tat) gene. Nature (1987) 1.93
The Tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi sarcoma and cytokine-activated vascular cells, induces adhesion of the same cell types by using integrin receptors recognizing the RGD amino acid sequence. Proc Natl Acad Sci U S A (1993) 1.93
Tat is required for efficient HIV-1 reverse transcription. EMBO J (1997) 1.90
The expression of the interleukin 6 gene is induced by the human immunodeficiency virus 1 TAT protein. J Exp Med (1994) 1.89
Human immunodeficiency viruses regulated by alternative trans-activators: genetic evidence for a novel non-transcriptional function of Tat in virion infectivity. EMBO J (1994) 1.78
Characterization of a cDNA clone encoding the visna virus transactivating protein. Proc Natl Acad Sci U S A (1989) 1.73
Repression of MHC class I gene promoter activity by two-exon Tat of HIV. Science (1993) 1.68
Antibodies to the HIV-1 Tat protein correlated with nonprogression to AIDS: a rationale for the use of Tat toxoid as an HIV-1 vaccine. J Hum Virol (1999) 1.65
Angiogenic properties of human immunodeficiency virus type 1 Tat protein. Proc Natl Acad Sci U S A (1995) 1.64
Sequence variations in human immunodeficiency virus type 1 Nef are associated with different stages of disease. J Virol (1999) 1.61
Equine infectious anemia virus tat: insights into the structure, function, and evolution of lentivirus trans-activator proteins. J Virol (1990) 1.61
Defective accessory genes in a human immunodeficiency virus type 1-infected long-term survivor lacking recoverable virus. J Virol (1995) 1.50
Persistence of attenuated rev genes in a human immunodeficiency virus type 1-infected asymptomatic individual. J Virol (1995) 1.48
Cyclin T1 domains involved in complex formation with Tat and TAR RNA are critical for tat-activation. J Mol Biol (1999) 1.40
Human immunodeficiency virus type 1 Tat upregulates interleukin-2 secretion in activated T cells. J Virol (1994) 1.29
Molecular biology and pathogenesis of animal lentivirus infections. Clin Microbiol Rev (1996) 1.26
Dual role of HIV Tat in regulation of apoptosis in T cells. J Immunol (1997) 1.25
A critical role for the TAR element in promoting efficient human immunodeficiency virus type 1 reverse transcription. J Virol (1996) 1.22
Regulation of HIV gene expression. AIDS (1995) 1.20
HIV-1 evolution and disease progression. Science (1996) 1.20
Demonstration that orf2 encodes the feline immunodeficiency virus transactivating (Tat) protein and characterization of a unique gene product with partial rev activity. J Virol (1999) 1.18
Human immunodeficiency virus type 1 TAR element revertant viruses define RNA structures required for efficient viral gene expression and replication. J Virol (1995) 1.13
Activation of expression of genes coding for extracellular matrix proteins in Tat-producing glioblastoma cells. Proc Natl Acad Sci U S A (1992) 1.08
Recombinant human immunodeficiency virus type 1 genomes with tat unconstrained by overlapping reading frames reveal residues in Tat important for replication in tissue culture. J Virol (1996) 1.04
Nucleotide sequence analysis of Jembrana disease virus: a bovine lentivirus associated with an acute disease syndrome. J Gen Virol (1995) 0.98
Identification and characterization of the bovine immunodeficiency-like virus tat gene. J Virol (1992) 0.97
The CAEV tat gene trans-activates the viral LTR and is necessary for efficient viral replication. Virology (1993) 0.92
Genomic sequence analysis identifies Jembrana disease virus as a new bovine lentivirus. J Gen Virol (1995) 0.90
Tat, Tat-associated kinase, and transcription. J Biomed Sci (1998) 0.88
HIV type 1 Tat protein enhances activation-but not Fas (CD95)-induced peripheral blood T cell apoptosis in healthy individuals. Int Immunol (1997) 0.88
Characterization of the Jembrana disease virus tat gene and the cis- and trans-regulatory elements in its long terminal repeats. J Virol (1999) 0.87
Sequences downstream of the RNA initiation site regulate human T-cell lymphotropic virus type I basal gene expression. J Virol (1993) 0.87
Characterization of cDNAs species encoding the Tat protein of caprine arthritis encephalitis virus. Virology (1994) 0.85
Down-modulation of cell surface expression of p80 form of the tumor necrosis factor receptor by human immunodeficiency virus-1 tat gene. Lymphokine Cytokine Res (1992) 0.85
Jembrana disease in Bali cattle. Aust Vet J (1976) 0.82
Recent advances in the understanding of Jembrana disease. Vet Microbiol (1995) 0.82
Functional analysis of simian immunodeficiency virus SIVAGM long terminal repeat. Virus Genes (1996) 0.76
Detection of specific human immunodeficiency virus type 1 Tat-TAR complexes in the presence of mild denaturing conditions. J Virol Methods (1997) 0.76
Global burden of obesity in 2005 and projections to 2030. Int J Obes (Lond) (2008) 9.45
Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials. JAMA (1999) 9.18
Safety and antitumor activity of recombinant soluble Apo2 ligand. J Clin Invest (1999) 7.69
Ordered rearrangement of immunoglobulin heavy chain variable region segments. EMBO J (1984) 6.67
Skeletal muscle lipid content and insulin resistance: evidence for a paradox in endurance-trained athletes. J Clin Endocrinol Metab (2001) 4.53
Regulation: positive control. Annu Rev Genet (1974) 4.34
Development of symptoms of tobacco dependence in youths: 30 month follow up data from the DANDY study. Tob Control (2002) 3.64
Pregnancy established in an infertile patient after transfer of a donated embryo fertilised in vitro. Br Med J (Clin Res Ed) (1983) 3.56
Attention-deficit hyperactivity disorder: a category or a continuum? Genetic analysis of a large-scale twin study. J Am Acad Child Adolesc Psychiatry (1997) 3.56
Skeletal muscle attenuation determined by computed tomography is associated with skeletal muscle lipid content. J Appl Physiol (1985) (2000) 3.54
Seeing the herpesvirus capsid at 8.5 A. Science (2000) 3.35
Effects of oral potassium on blood pressure. Meta-analysis of randomized controlled clinical trials. JAMA (1997) 3.27
An improved DNA sequencing strategy. Anal Biochem (1985) 3.22
The analgesic effect of sucrose in full term infants: a randomised controlled trial. BMJ (1995) 3.09
Prevalence of diabetes and impaired fasting glucose in the Chinese adult population: International Collaborative Study of Cardiovascular Disease in Asia (InterASIA). Diabetologia (2003) 3.00
Activation of a translocated human c-myc gene by an enhancer in the immunoglobulin heavy-chain locus. Nature (1984) 2.93
Immune response in silico (IRIS): immune-specific genes identified from a compendium of microarray expression data. Genes Immun (2005) 2.69
Regulation of the L-arabinose operon BAD in vitro. J Biol Chem (1974) 2.68
Complete genome sequence of the shrimp white spot bacilliform virus. J Virol (2001) 2.58
Mice bearing a targeted interruption of the homeobox gene HOXA9 have defects in myeloid, erythroid, and lymphoid hematopoiesis. Blood (1997) 2.55
Serum cholesterol in young men and subsequent cardiovascular disease. N Engl J Med (1993) 2.55
Assembly of VP26 in herpes simplex virus-1 inferred from structures of wild-type and recombinant capsids. Nat Struct Biol (1995) 2.51
DNA sequence of the araBAD promoter in Escherichia coli B/r. Proc Natl Acad Sci U S A (1978) 2.51
Effect of intramural, subserosal, and submucosal uterine fibroids on the outcome of assisted reproductive technology treatment. Fertil Steril (1998) 2.47
Spinal cord stimulation facilitates functional walking in a chronic, incomplete spinal cord injured. Spinal Cord (2002) 2.47
Effects of alcohol reduction on blood pressure: a meta-analysis of randomized controlled trials. Hypertension (2001) 2.42
p110delta, a novel phosphatidylinositol 3-kinase catalytic subunit that associates with p85 and is expressed predominantly in leukocytes. J Biol Chem (1997) 2.37
Synovial fluid lymphocytes differ from peripheral blood lymphocytes in patients with rheumatoid arthritis. J Immunol (1982) 2.22
Pharmacological prevention of sevoflurane- and desflurane-related emergence agitation in children: a meta-analysis of published studies. Br J Anaesth (2010) 2.17
A method to perform direct transcutaneous intrathecal injection in rats. J Pharmacol Toxicol Methods (1994) 2.16
cDNA cloning of an intracellular form of the human interleukin 1 receptor antagonist associated with epithelium. Proc Natl Acad Sci U S A (1991) 2.16
The sand seas of Titan: Cassini RADAR observations of longitudinal dunes. Science (2006) 2.11
Regulation of the araC gene of Escherichia coli: catabolite repression, autoregulation, and effect on araBAD expression. Proc Natl Acad Sci U S A (1984) 2.10
IL-10, T lymphocyte inhibitor of human blood cell production of IL-1 and tumor necrosis factor. J Immunol (1992) 2.09
Legume consumption and risk of coronary heart disease in US men and women: NHANES I Epidemiologic Follow-up Study. Arch Intern Med (2001) 2.08
Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease. J Clin Invest (1996) 2.07
Electron correlation effects in resonant inelastic X-ray scattering of NaV2O5. Phys Rev Lett (2002) 2.06
Direction of transcription of the regulatory gene araC in Escherichia coli B-r. Proc Natl Acad Sci U S A (1974) 2.05
The viral envelope gene is involved in macrophage tropism of a human immunodeficiency virus type 1 strain isolated from brain tissue. J Virol (1990) 2.04
Coffee consumption and serum lipids: a meta-analysis of randomized controlled clinical trials. Am J Epidemiol (2001) 2.03
Factors associated with HIV prevalence in a pre-partum cohort of Zambian women. Int J STD AIDS (2006) 2.02
A clinical assessment of foetal diagnostic methods. J Obstet Gynaecol Br Commonw (1967) 2.02
Comparison of patients' needs for information on prostate surgery with printed materials provided by surgeons. Qual Health Care (1995) 2.00
The use of synthetic oligodeoxyribonucleotides to produce specific deletions in the araBAD promoter of Escherichia coli B/r. Gene (1982) 1.98
The lakes of Titan. Nature (2007) 1.97
Interaction of the regulatory gene product with the operator site in the L-arabinose operon of Escherichia coli. J Mol Biol (1974) 1.97
Long-term absolute benefit of lowering blood pressure in hypertensive patients according to the JNC VI risk stratification. Hypertension (2000) 1.96
A rapid high-yield purification procedure for the cyclic adenosine 3',5'-monophosphate receptor protein from Escherichia coli. Biochim Biophys Acta (1978) 1.93
Diversity and joining segments of mouse immunoglobulin heavy chain genes are closely linked and in the same orientation: implications for the joining mechanism. Proc Natl Acad Sci U S A (1983) 1.93
Developmental regulation of transcription by a tissue-specific TAF homolog. Genes Dev (2001) 1.92
In vitro activation of the transcription of araBAD operon by araC activator. Proc Natl Acad Sci U S A (1974) 1.91
Increased frequency of rheumatoid factor precursor B lymphocytes after immunization of normal adults with tetanus toxoid. Clin Exp Immunol (1983) 1.88
Molecularly cloned SHIV-1157ipd3N4: a highly replication- competent, mucosally transmissible R5 simian-human immunodeficiency virus encoding HIV clade C Env. J Virol (2006) 1.87
Human herpesvirus type 8 DNA sequences in cell-free plasma and mononuclear cells of Kaposi's sarcoma patients. J Infect Dis (1996) 1.85
In vitro maturation and the fertilization and developmental competence of oocytes recovered from untreated polycystic ovarian patients. Fertil Steril (1994) 1.83
An acute ischemic stroke classification instrument that includes CT or MR angiography: the Boston Acute Stroke Imaging Scale. AJNR Am J Neuroradiol (2008) 1.80
Causes of death among people with convulsive epilepsy in rural West China: a prospective study. Neurology (2011) 1.77
Autoimmune disease in mice due to integration of an endogenous retrovirus in an apoptosis gene. J Exp Med (1993) 1.75
Crystal structure of a calcium-phospholipid binding domain from cytosolic phospholipase A2. J Biol Chem (1998) 1.75
The araIc mutation in Escherichia coli B/r. J Bacteriol (1981) 1.73
Cumulative lifetime migraine incidence in women and men. Cephalalgia (2008) 1.73
Isolation of ara-lac gene fusions in Salmonella typhimurium LT2 by using transducing bacteriophage Mu d (Apr lac). J Bacteriol (1980) 1.72
Mutations in the protein kinase A R1alpha regulatory subunit cause familial cardiac myxomas and Carney complex. J Clin Invest (2000) 1.72
Delayed recovery following acute gastroenteritis. Acta Paediatr Belg (1977) 1.71
Prevalence, awareness, treatment and control of hypertension in North America, North Africa and Asia. J Hum Hypertens (2004) 1.71
Rheumatoid factor and immune networks. Annu Rev Immunol (1987) 1.70
Long-term controlled normoglycemia in diabetic non-human primates after transplantation with hCD46 transgenic porcine islets. Am J Transplant (2009) 1.69
The effect of adrenergic receptor blocking drugs on the human uterus. J Obstet Gynaecol Br Commonw (1968) 1.67
Auscultation of foetal heart rate: an assessment of its error and significance. Br Med J (1968) 1.67
Validation of conditions for efficient detection of HPRT and APRT mutations in suspension-cultured Chinese hamster ovary cells. Mutat Res (1980) 1.67
New directions in information for patients. BMJ (1995) 1.67
A clinical assessment of nine pregnancies obtained by in vitro fertilization and embryo transfer. Fertil Steril (1981) 1.67
Deoxyribonucleic acid sequence of araBAD promoter mutants of Escherichia coli. J Bacteriol (1980) 1.66
A common idiotope on human rheumatoid factors identified by a hybridoma antibody. Mol Immunol (1983) 1.65
Expression of zebrafish bHLH genes ngn1 and nrd defines distinct stages of neural differentiation. Dev Dyn (1998) 1.63
DNA sequence of the araC regulatory gene from Escherichia coli B/r. Nucleic Acids Res (1980) 1.62
Effect of delayed insemination on in-vitro fertilization, culture and transfer of human embryos. J Reprod Fertil (1982) 1.62
Energy balance, nitrogen balance, and growth in preterm infants fed expressed breast milk, a premature infant formula, and two low-solute adapted formulae. Arch Dis Child (1982) 1.62
MDM2 regulates MYCN mRNA stabilization and translation in human neuroblastoma cells. Oncogene (2011) 1.59
[IMPaCCT: standards of paediatric palliative care]. Schmerz (2008) 1.59
Cumulative pregnancy and live birth rates in women with antiphospholipid antibodies undergoing assisted reproduction. Hum Reprod (1999) 1.59
Dyspepsia and irritable bowel syndrome in China: a population-based endoscopy study of prevalence and impact. Aliment Pharmacol Ther (2010) 1.59
Use of monoclonal antibodies to analyze peripheral blood and salivary gland lymphocyte subsets in Sjögren's syndrome. Arthritis Rheum (1982) 1.58
Identification of a cellular protein that interacts and synergizes with the RTA (ORF50) protein of Kaposi's sarcoma-associated herpesvirus in transcriptional activation. J Virol (2001) 1.58
The establishment and maintenance of pregnancy using in vitro fertilization and embryo donation in a patient with primary ovarian failure. Nature (1984) 1.58
Cholera toxin suppresses interleukin (IL)-12 production and IL-12 receptor beta1 and beta2 chain expression. J Exp Med (1999) 1.58
Characterization of the Erwinia carotovora pelB gene and its product pectate lyase. J Bacteriol (1987) 1.57
Controlled trial of fetal intensive care. Am J Obstet Gynecol (1976) 1.57
Tonotopic organization of auditory cortical fields delineated by parvalbumin immunoreactivity in macaque monkeys. J Comp Neurol (1997) 1.57
Plumage and mitochondrial DNA haplotype variation across a moving hybrid zone. Evolution (2001) 1.57
Quorum sensing differentially regulates Pseudomonas aeruginosa type VI secretion locus I and homologous loci II and III, which are required for pathogenesis. Microbiology (2009) 1.56
Neurogenesis in adolescent brain is potently inhibited by ethanol. Neuroscience (2005) 1.56
Clinical review 92: Phytoestrogens. J Clin Endocrinol Metab (1998) 1.55
Vicariance biogeography in the Pleistocene and speciation in North American wood warblers: a test of Mengel's model. Proc Natl Acad Sci U S A (1992) 1.55
Regulation of Epstein-Barr virus infection by recombinant interferons. Selected sensitivity to interferon-gamma. Eur J Immunol (1985) 1.55
Transactivation of human immunodeficiency virus promoter by human herpesvirus 6. J Virol (1989) 1.53
Case-control study of intracranial meningiomas in women in Los Angeles County, California. J Natl Cancer Inst (1980) 1.52
The UK Northern region genetic register for familial adenomatous polyposis coli: use of age of onset, congenital hypertrophy of the retinal pigment epithelium, and DNA markers in risk calculations. J Med Genet (1991) 1.51
Characterization of pigmented fungi by melanin staining. Am J Dermatopathol (1983) 1.50
Anti-hypervariable region antibody induced by a defined peptide: an approach for studying the structural correlates of idiotypes. Proc Natl Acad Sci U S A (1984) 1.50